KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on May 19, 2026 - 3:59PM >>  ABB India 6338.1  [ -1.25% ]  ACC 1358.2  [ -0.08% ]  Ambuja Cements 432.7  [ 0.62% ]  Asian Paints 2601.15  [ -0.44% ]  Axis Bank 1238.6  [ 0.02% ]  Bajaj Auto 10230.1  [ 0.31% ]  Bank of Baroda 260.4  [ 0.12% ]  Bharti Airtel 1916  [ -1.14% ]  Bharat Heavy 401.4  [ 1.58% ]  Bharat Petroleum 286.05  [ 1.85% ]  Britannia Industries 5410.5  [ 0.62% ]  Cipla 1409.95  [ -1.17% ]  Coal India 456.7  [ -1.14% ]  Colgate Palm 2190.2  [ 1.74% ]  Dabur India 453.3  [ -0.73% ]  DLF 576.15  [ 0.51% ]  Dr. Reddy's Lab. 1329.2  [ -0.17% ]  GAIL (India) 156.55  [ -2.28% ]  Grasim Industries 2938  [ -0.19% ]  HCL Technologies 1184.5  [ 3.29% ]  HDFC Bank 764.7  [ -0.50% ]  Hero MotoCorp 5009.4  [ 1.08% ]  Hindustan Unilever 2238.1  [ -0.75% ]  Hindalco Industries 1048.5  [ -0.38% ]  ICICI Bank 1242.3  [ -0.69% ]  Indian Hotels Co. 655.5  [ 1.12% ]  IndusInd Bank 897.15  [ 0.53% ]  Infosys 1195.3  [ 4.63% ]  ITC 311.5  [ 0.44% ]  Jindal Steel 1228  [ -0.32% ]  Kotak Mahindra Bank 380.95  [ -2.74% ]  L&T 3927.3  [ 0.21% ]  Lupin 2288.5  [ 1.58% ]  Mahi. & Mahi 3106  [ 0.74% ]  Maruti Suzuki India 13002.5  [ -0.09% ]  MTNL 29.18  [ 1.78% ]  Nestle India 1432.4  [ 0.00% ]  NIIT 64.07  [ 3.66% ]  NMDC 89.18  [ -1.08% ]  NTPC 389.65  [ 0.53% ]  ONGC 296.35  [ -0.29% ]  Punj. NationlBak 101.25  [ 1.71% ]  Power Grid Corpn. 299  [ 0.86% ]  Reliance Industries 1326.8  [ -0.63% ]  SBI 950.35  [ 1.10% ]  Vedanta 334.85  [ 2.43% ]  Shipping Corpn. 339.55  [ -1.48% ]  Sun Pharmaceutical 1885  [ -1.06% ]  Tata Chemicals 737.45  [ 1.02% ]  Tata Consumer 1213  [ -1.45% ]  Tata Motors Passenge 361.9  [ 2.52% ]  Tata Steel 209.6  [ -0.12% ]  Tata Power Co. 416.1  [ 2.89% ]  Tata Consult. Serv. 2334.4  [ 2.20% ]  Tech Mahindra 1469.65  [ 2.74% ]  UltraTech Cement 11369  [ -1.57% ]  United Spirits 1305.4  [ -0.75% ]  Wipro 195.5  [ 1.72% ]  Zee Entertainment 87.75  [ 3.66% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    ALEMBIC PHARMACEUTICALS LTD.

    19 May 2026 | 03:59

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE901L01018 BSE Code / NSE Code 533573 / APLLTD Book Value (Rs.) 277.42 Face Value 2.00
    Bookclosure 29/07/2025 52Week High 1108 EPS 34.33 P/E 21.88
    Market Cap. 14763.86 Cr. 52Week Low 636 P/BV / Div Yield (%) 2.71 / 1.60 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Alembic Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(3) 202512(3) 202512(3) 202509(3)
    OprtIncome Alembic Pharmaceuticals Ltd. 1718.74 1642.24 Aarey Drugs & Pharmaceuticals Ltd. 96.43 84.16
    OtherRecurrInc Alembic Pharmaceuticals Ltd. 25.88 10.73 Aarey Drugs & Pharmaceuticals Ltd. 4.18 0.79
    Operating profit Alembic Pharmaceuticals Ltd. 191.75 191.93 Aarey Drugs & Pharmaceuticals Ltd. -2.34 1.95
    GrossProfit Alembic Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Alembic Pharmaceuticals Ltd. 243.07 114.47 Aarey Drugs & Pharmaceuticals Ltd. 0.57 1.02
    Equity Capital Alembic Pharmaceuticals Ltd. 39.31 39.31 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Alembic Pharmaceuticals Ltd. 11.15 11.68 Aarey Drugs & Pharmaceuticals Ltd. -2.42 2.31
    GPM Alembic Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Alembic Pharmaceuticals Ltd. 14.14 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.59 1.21

    Annual Trends

    Alembic Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202503(12) 202403(12)
    OperatingIncome Alembic Pharmaceuticals Ltd. 6651.38 6032.63 Aarey Drugs & Pharmaceuticals Ltd. 473.94 395.62
    OperatingProfit Alembic Pharmaceuticals Ltd. 1062.71 901.39 Aarey Drugs & Pharmaceuticals Ltd. 2.90 4.45
    OtherRecurrInc Alembic Pharmaceuticals Ltd. 55.90 47.88 Aarey Drugs & Pharmaceuticals Ltd. 9.81 6.96
    AdjustedPBT Alembic Pharmaceuticals Ltd. 721.10 595.72 Aarey Drugs & Pharmaceuticals Ltd. 6.10 5.34
    ReportedPAT Alembic Pharmaceuticals Ltd. 640.42 503.12 Aarey Drugs & Pharmaceuticals Ltd. 4.02 4.68
    EquityDividend Alembic Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Alembic Pharmaceuticals Ltd. 39.31 39.31 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.05
    PreferenceCapital Alembic Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Alembic Pharmaceuticals Ltd. 5575.95 5155.43 Aarey Drugs & Pharmaceuticals Ltd. 107.51 102.25
    LoanFunds Alembic Pharmaceuticals Ltd. 1149.49 1142.22 Aarey Drugs & Pharmaceuticals Ltd. 34.86 31.35
    AL_CurrentLiabilities Alembic Pharmaceuticals Ltd. 1386.50 1219.31 Aarey Drugs & Pharmaceuticals Ltd. 117.26 139.17
    NetBlock Alembic Pharmaceuticals Ltd. 3511.82 2513.47 Aarey Drugs & Pharmaceuticals Ltd. 16.22 12.96
    Investments Alembic Pharmaceuticals Ltd. 271.40 259.56 Aarey Drugs & Pharmaceuticals Ltd. 2.12 1.38
    TotCurrentAssets Alembic Pharmaceuticals Ltd. 4368.03 3946.01 Aarey Drugs & Pharmaceuticals Ltd. 272.26 288.95

    Ratios

    Alembic Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202503(12) 202403(12)
    OPM Alembic Pharmaceuticals Ltd. 15.97 14.94 Aarey Drugs & Pharmaceuticals Ltd. 0.61 1.12
    NPM Alembic Pharmaceuticals Ltd. 9.62 8.33 Aarey Drugs & Pharmaceuticals Ltd. 0.84 1.18
    Reported EPS Alembic Pharmaceuticals Ltd. 32.58 25.60 Aarey Drugs & Pharmaceuticals Ltd. 1.43 1.67
    Return on Networth Alembic Pharmaceuticals Ltd. 11.40 9.68 Aarey Drugs & Pharmaceuticals Ltd. 2.95 3.59
    Debt/ Equity Alembic Pharmaceuticals Ltd. 0.20 0.21 Aarey Drugs & Pharmaceuticals Ltd. 0.25 0.24
    Financial Charges Coverage Ratio Alembic Pharmaceuticals Ltd. 12.93 12.41 Aarey Drugs & Pharmaceuticals Ltd. 2.73 2.61
    Current Ratio Alembic Pharmaceuticals Ltd. 3.15 3.24 Aarey Drugs & Pharmaceuticals Ltd. 2.32 2.08
    Dividend per share Alembic Pharmaceuticals Ltd. 0.00 11.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.